Algorithmic Biologics, a deep-tech startup building algorithms for molecular programming, has received an undisclosed amount of seed funding from Axilor Lab. Axilor Labs is a venture curation initiative by Axilor to accelerate the commercial success of transformative ideas around global challenges facing human health and wellness. The start up aims to support ideas at the impactful proof-of-science stage and build start-ups together with innovators where the impact of transformative tech is realised commercially.

ABPL’s platform technology works like a compression algorithm for molecular testing and has applications in healthcare, pharmaceuticals, agriculture, animal husbandry, food safety, synthetic biology, and molecular biology research. ABPL is working with leading brand names across industries to provide smarter molecular testing for food safety-related applications and seed R&D. 

Algorithmic Biologics plans to use the funds to unlock and scale these applications commercially, as well as extend their IP portfolio to create more building blocks of molecular technologies towards its vision of creating a computing platform to analyse data.